Oral contraceptive pills based on gestodene Review article
Article Sidebar
Published:
Sep 30, 2016
Keywords:
hormonal contraception, gestodene
Main Article Content
Abstract
Contraceptive efficacy, tolerability, incidence of adverse effects/events, safety and treatment convenience especially in woman with clinically significant medical history, bad habits or hormonal intolerance – are a key criteria for selection of best contraceptive method.
Article Details
How to Cite
Tomaszewski, J. (2016). Oral contraceptive pills based on gestodene. Medycyna Faktow (J EBM), 9(3(32), 244-248. Retrieved from https://journalsmededu.pl/index.php/jebm/article/view/2230
Issue
Section
Articles
Copyright © by Medical Education. All rights reserved.
References
1. Merki-Feld G.S., Gruber I.M.L.: Broad Counseling for Adolescents About Combined Hormonal Contraceptive Methods: The Choice Study. J. Adolesc. Health. 2014; 54: 404e-409e.
2. Davis M.G., Reape K.Z., Hait H.: A look at the long-term safety of an extended-regimen OC. J. Fam. Pract. 2010; 59(5): E3.
3. Graham C.A., Panicker S., Shawe J. et al.: Women’s experiences with tailored use of combined oral contraceptive: a qualitative study. Human Reprod. 2013; 28: 1620-1625.
4. Stanczyk F.Z., Archer D.F.: Gestodene: A review of its pharmacology, potency and tolerability in combined contraceptive preparations. Contraception 2014; 89: 242-252.
5. Szarewski A., Mansour D., Shulman L.P.: 50 years of “The Pill”: celebrating a golden anniversary. J. Fam. Plann. Reprod. Health. Care. 2010; 36: 231-238.
6. ACOG Practice Bulletin No. 110: Noncontraceptive uses of hormonal contraceptives. Obstet. Gynecol. 2010; 115: 206-218.
7. Edelman A., Micks E., Gallo M.F. et al.: Continous or extended cycle vs. cyclic use of combined hormonal contraceptives for contraception (Review). Cochrane Database Syst. Rev. 2014; 7: CD004695 [doi: 10.1002/14651858.CD004695.pub3].
8. Shrader S., Dickerson L.M.: Extended and continuous – cycle oral contraceptive. Pharmacother. 2008; 28: 1033-1040.
9. Hicks C.W., Rome E.S.: Menstrual manipulation: options for suppressing the cycle. Cleveland Clin. J. Med. 2010; 77: 445-453.
10. Jacobson J.C., Likis F.E., Murphy P.A.: Extended and contiuous combined contraceptive regimens for menstrual suppression. J. Midwifery Womens Health 2012; 57: 585-592.
11. Burkman R., Bell C., Serfaty D.: The evolution of combined oral contraception: improving the risk-to-benefit ratio. Contraception 2010; 84: 19-34.
12. Christin-Maitre S.: History of oral contraceptive drugs and their use worldwide. Best Pract. Res. Clin. Endocrinol. Metab. 2013; 27: 3-12.
2. Davis M.G., Reape K.Z., Hait H.: A look at the long-term safety of an extended-regimen OC. J. Fam. Pract. 2010; 59(5): E3.
3. Graham C.A., Panicker S., Shawe J. et al.: Women’s experiences with tailored use of combined oral contraceptive: a qualitative study. Human Reprod. 2013; 28: 1620-1625.
4. Stanczyk F.Z., Archer D.F.: Gestodene: A review of its pharmacology, potency and tolerability in combined contraceptive preparations. Contraception 2014; 89: 242-252.
5. Szarewski A., Mansour D., Shulman L.P.: 50 years of “The Pill”: celebrating a golden anniversary. J. Fam. Plann. Reprod. Health. Care. 2010; 36: 231-238.
6. ACOG Practice Bulletin No. 110: Noncontraceptive uses of hormonal contraceptives. Obstet. Gynecol. 2010; 115: 206-218.
7. Edelman A., Micks E., Gallo M.F. et al.: Continous or extended cycle vs. cyclic use of combined hormonal contraceptives for contraception (Review). Cochrane Database Syst. Rev. 2014; 7: CD004695 [doi: 10.1002/14651858.CD004695.pub3].
8. Shrader S., Dickerson L.M.: Extended and continuous – cycle oral contraceptive. Pharmacother. 2008; 28: 1033-1040.
9. Hicks C.W., Rome E.S.: Menstrual manipulation: options for suppressing the cycle. Cleveland Clin. J. Med. 2010; 77: 445-453.
10. Jacobson J.C., Likis F.E., Murphy P.A.: Extended and contiuous combined contraceptive regimens for menstrual suppression. J. Midwifery Womens Health 2012; 57: 585-592.
11. Burkman R., Bell C., Serfaty D.: The evolution of combined oral contraception: improving the risk-to-benefit ratio. Contraception 2010; 84: 19-34.
12. Christin-Maitre S.: History of oral contraceptive drugs and their use worldwide. Best Pract. Res. Clin. Endocrinol. Metab. 2013; 27: 3-12.